clofibric acid has been researched along with d-alpha tocopherol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Beaty, MM; Borges, T; Chen, LC; Chow, CK; Clark, TD; Clark, TL; Glauert, HP; Greenwell, WS; Srinivasan, SR; Tatum, V | 1 |
| Chow, CK; Glauert, HP; Srinivasan, SR | 1 |
| Glauert, HP; Li, Y; Spear, BT | 1 |
| Calfee-Mason, KG; Glauert, HP; Spear, BT | 1 |
| Miller, AG; Wilkinson-Berka, JL | 1 |
| Calfee-Mason, KG; Glauert, HP; Lee, EY; Spear, BT | 1 |
2 review(s) available for clofibric acid and d-alpha tocopherol
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Update on the treatment of diabetic retinopathy.
Topics: Adrenal Cortex Hormones; Aldehyde Reductase; Angiotensin II; Antihypertensive Agents; Blood Glucose; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dyslipidemias; Enzyme Inhibitors; Glycation End Products, Advanced; Human Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Insulin; Laser Coagulation; Protein Kinase C; Vascular Endothelial Growth Factor A; Vitamin E | 2008 |
5 other study(ies) available for clofibric acid and d-alpha tocopherol
| Article | Year |
|---|---|
Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate.
Topics: Adenosine Triphosphatases; Animals; Clofibrate; Clofibric Acid; Drug Synergism; Female; Fibric Acids; gamma-Glutamyltransferase; Glucose-6-Phosphatase; Liver; Liver Neoplasms, Experimental; Rats; Rats, Inbred Strains; Vitamin E | 1990 |
Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
Topics: Administration, Oral; Animals; Body Weight; Clofibrate; Clofibric Acid; DNA; Female; Fibric Acids; Hepatectomy; Hypolipidemic Agents; Liver; Organ Size; Rats; Rats, Inbred Strains; Vitamin E | 1990 |
Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.
Topics: Acetylcysteine; Animals; Antioxidants; Clofibric Acid; Drug Interactions; Fibric Acids; Humans; Liver Neoplasms, Experimental; NF-kappa B; Peroxisome Proliferators; Rats; Reactive Oxygen Species; Tumor Cells, Cultured; Vitamin E | 2000 |
Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprofibrate.
Topics: Administration, Oral; Animals; Antioxidants; Clofibric Acid; Fibric Acids; Liver; Male; NF-kappa B; Peroxisome Proliferators; Rats; Rats, Sprague-Dawley; Vitamin E | 2004 |
Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
Topics: Acyl-CoA Oxidase; Animals; Apoptosis; Blotting, Western; Body Weight; Cell Nucleus; Clofibric Acid; Cyclins; Diet; DNA; Electrophoretic Mobility Shift Assay; Female; Fibric Acids; Glutathione; Liver; Mice; NF-kappa B p50 Subunit; Nuclease Protection Assays; Organ Size; Peroxisome Proliferators; RNA; Transcription Factor RelA; Vitamin E | 2008 |